Inhibikase Therapeutics, Inc. (IKT) SEC Filings https://www.inhibikase.com/investors/sec-filings/all-sec-filings/rss Inhibikase Therapeutics, Inc. (IKT) - All SEC Filings en-us https://d1io3yog0oux5.cloudfront.net/_36dbb71928886c79e446b0ffcae1c0b0/inhibikase/files/theme/images/logo-sm.png Inhibikase Therapeutics, Inc. Logo /investors Equisolve Investor Relations Suite <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-26-290477/0001193125-26-290477.pdf Tue, 30 Jun 26 16:06:07 -0400 https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-26-290477/0001193125-26-290477.pdf <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-26-290472/0001193125-26-290472.pdf Tue, 30 Jun 26 16:05:50 -0400 https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-26-290472/0001193125-26-290472.pdf <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-26-290470/0001193125-26-290470.pdf Tue, 30 Jun 26 16:05:45 -0400 https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-26-290470/0001193125-26-290470.pdf <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-26-290474/0001193125-26-290474.pdf Tue, 30 Jun 26 16:05:40 -0400 https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-26-290474/0001193125-26-290474.pdf <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-26-290476/0001193125-26-290476.pdf Tue, 30 Jun 26 16:05:36 -0400 https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-26-290476/0001193125-26-290476.pdf <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-26-290475/0001193125-26-290475.pdf Tue, 30 Jun 26 16:05:31 -0400 https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-26-290475/0001193125-26-290475.pdf <![CDATA[8-K - Current report]]> https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-26-286747/0001193125-26-286747.pdf Mon, 29 Jun 26 06:05:48 -0400 https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-26-286747/0001193125-26-286747.pdf <![CDATA[SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors]]> https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001104659-26-062874/0001104659-26-062874.pdf Fri, 15 May 26 20:13:31 -0400 https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001104659-26-062874/0001104659-26-062874.pdf <![CDATA[SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors]]> https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001493152-26-023791/0001493152-26-023791.pdf Fri, 15 May 26 16:31:49 -0400 https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001493152-26-023791/0001493152-26-023791.pdf <![CDATA[SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors]]> https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001831942-26-000019/0001831942-26-000019.pdf Fri, 15 May 26 16:21:19 -0400 https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001831942-26-000019/0001831942-26-000019.pdf